Direct Oral Anticoagulants and Prevention of Dementia in Nonvalvular Atrial Fibrillation

被引：2
|
作者：
Pendlebury, Sarah T. [1 ,2 ]
机构：
[1] Univ Oxford, Nuffield Dept Clin Neurosci, Wolfson Ctr Prevent Stroke & Dementia, Oxford, England
[2] Oxford Univ Hosp NHS Fdn Trust, Dept Med & Geratol, NIHR Biomed Res Ctr, Oxford, England
来源：
STROKE | 2021年 / 52卷 / 11期
关键词：
Editorials; anticoagulant; atrial fibrillation; dementia; risk factor; INCIDENT DEMENTIA; PREVALENCE; STROKE; RISK;
D O I：
10.1161/STROKEAHA.121.035664
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3469 / 3471
页数：3
相关论文
共 50 条
  • [21] Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Deitelzweig, Steven
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 74 - 81
  • [22] Stroke Prevention in Nonvalvular Atrial Fibrillation: Update on Target-Specific Oral Anticoagulants
    Patrick, Carol
    Clarke, Randi
    JOURNAL OF CONTINUING EDUCATION IN NURSING, 2015, 46 (04): : 152 - 154
  • [23] Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis
    Tervonen, Tommi
    Ustyugova, Anastasia
    Bhashyam, Sumitra Sri
    Lip, Gregory Y. H.
    Verdecchia, Paolo
    Kwan, Ryan
    Gropper, Savion
    Heinrich-Nols, Jutta
    Marsh, Kevin
    VALUE IN HEALTH, 2017, 20 (10) : 1394 - 1402
  • [24] Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    Lee, Hsin-Fu
    See, Lai-Chu
    Tu, Hui-Tzu
    Chao, Tze-Fan
    Yeh, Yung-Hsin
    Wu, Lung-Sheng
    Kuo, Chi-Tai
    Chang, Shang-Hung
    Lip, Gregory Y. H.
    CHEST, 2019, 156 (03) : 529 - 543
  • [25] Reduced Doses of Direct Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation
    Deguchi, Ichiro
    Takao, Masaki
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (02): : 354 - 359
  • [26] EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH MULTIMORBIDITY
    Dhamane, Amol
    Ferri, Mauricio
    Keshishian, Allison
    Russ, Cristina
    Thomas, Ruth
    Leung, Gary
    Emir, Birol
    Yuce, Huseyin
    Di Fusco, Manuela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1598 - 1598
  • [27] Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing
    Farmakis, Dimitrios
    Davlouros, Periklis
    Giamouzis, Gregory
    Giannakoulas, George
    Pipilis, Athanasios
    Tsivgoulis, Georgios
    Parissis, John
    CARDIOLOGY, 2018, 140 (02) : 126 - 132
  • [28] Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation
    Trujillo, Toby C.
    Dobesh, Paul P.
    Crossley, George H.
    Finks, Shannon W.
    PHARMACOTHERAPY, 2019, 39 (01): : 94 - 108
  • [29] The Use of Direct Oral Anticoagulants for Prevention of Stroke and Systemic Embolic Events in East Asian Patients with Nonvalvular Atrial Fibrillation
    Ma, Chang-Sheng
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2018, 3 (02) : 215 - 226
  • [30] Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients
    Hye-Yoon Song
    Kyung-Bok Son
    Ju-Young Shin
    SeungJin Bae
    International Journal of Clinical Pharmacy, 2019, 41 : 1434 - 1441
12345